A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
for Rheumatoid Arthritis (RA)
Sites in Duncansville +2 more locations
Sponsor: SynAct Pharma Aps
Sex: All·Age: 18+
Code: NCT06671054·Phase 2·Recruiting·Listed Nov 2024